Furthermore, we observed notable metabolic differences between tumor tissues and adjacent tissues with significant interactions involving FGL1-LAG3 being negatively correlated with T cell subset numbers, indicating down-regulation of immune pathways and highlighting their immunosuppressive effects in liver cancer [37–39]. The gene discussed is FGL1; the disease is liver cancer.